medRxiv Preprints

{
  "doi": "10.1101/2025.11.23.25340799",
  "url": "https://www.medrxiv.org/content/10.1101/2025.11.23.25340799v4",
  "title": "Tryptophan metabolites are associated with gut-brain alterations in functional dyspepsia",
  "source": "medrxiv",
  "authors": "Ceulemans, M.; Wauters, L.; Weltens, N.; Vandermeulen, G.; de Loor, H.; Evenepoel, P.; Tito Tadeo, R. Y.; Vich Vila, A.; Derrien, M.; Dalile, B.; Tack, J.; Verbeke, K.; Raes, J.; Van Oudenhove, L.; Vanuytsel, T.",
  "version": "4",
  "abstract": "IntroductionDisturbances in the microbiota-gut-brain axis are thought to contribute to the pathophysiology of disorders of gut-brain interaction, including functional dyspepsia (FD), although comprehensive human data remain scarce. We aimed to study the relationships among microbiota-produced metabolites including tryptophan metabolites and short-chain fatty acids (SCFA), and functional brain connectivity in FD, in relation to symptomatology. MethodsIn 46 patients with Rome IV-diagnosed FD and 30 healthy controls (HC), targeted metabolomics using chromatography and mass spectrometry was conducted to quantify metabolites in blood, urine, and stool. Associations with gut microbiota and symptomatology were tested using fecal quantitative microbiota profiling and validated symptom questionnaires. Resting-state functional magnetic resonance imaging in 27 patients and 36 HC enabled analysis of functional connectivity in selected brain networks. ResultsPatients with FD exhibited distinct profiles of tryptophan metabolites and SCFA with higher urinary indole-3-acetate (IAA, P=0.018), lower serum kynurenine (P=0.030) and lower plasma propionate (P=0.0055) concentrations. FD-specific metabol",
  "category": "gastroenterology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Tim Vanuytsel",
  "journal_published_doi": null,
  "corresponding_institution": "Katholieke Universiteit Leuven"
}

{
  "doi": "10.64898/2026.07.26.26358975",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.26.26358975v1",
  "title": "Etiology and incidence of diarrhea requiring hospitalization in children under 5 years of age in 31 low- and middle-income countries: findings from the Global Pediatric Diarrhea Surveillance network, 2017-2022",
  "source": "medrxiv",
  "authors": "Soeters, H. M.; Antoni, S.; Iyer, S. S.; Weldegebriel, G.; Biey, J.; Mwenda, J. M.; Rey-Benito, G.; Ortiz, C.; Pastore, R.; Videbaek, D.; Singh, S.; Njambe, E.; Sangal, L.; Dhongde, D.; Grabovac, V.; Logronio, J.; Fahmy, K.; Ghoniem, A.; Armah, G.; Dennis, F. E.; Seheri, M. L.; Magagula, N.; Rakau-Nondela, K.; Fumian, T. M.; Maciel, I. T. A.; Samoilovich, E.; Semeiko, G.; Varghese, T.; Thomas, S.; Bines, J.; Li, D.; Kabir, F.; Liu, J.; Houpt, E. R.; Gautam, R.; Mirza, S. A.; Vinje, J.; Mulders, M. N.; Tate, J. E.; Parashar, U. D.; Platts-Mills, J. A.",
  "version": "1",
  "abstract": "Diarrhea remains a leading cause of child morbidity and mortality. Improved and ongoing estimates of the etiology of hospitalized pediatric diarrhea in low- and middle-income countries (LMICs) are needed to help prioritize and evaluate the use of existing and upcoming vaccines and interventions. The Global Pediatric Diarrhea Surveillance (GPDS) network is a World Health Organization (WHO)-coordinated public health surveillance network investigating the etiology of hospitalized diarrhea among children aged <5 years in LMICs. The GPDS network enrolls children hospitalized with diarrhea at 38 sentinel surveillance sites in 31 LMICs. Randomly selected stool specimens were tested by TaqMan Array Card quantitative reverse-transcription polymerase chain reaction (qPCR) for 16 pathogens associated with diarrhea. We estimated pathogen-specific attributable fractions (AFs) and incidence of diarrheal hospitalizations at the global, regional, and country levels during 3 time periods: 2017-2018, 2019-2020, and 2021-2022, with a focus on the most recent results. During 2017-2022, the GPDS network enrolled 70,750 children aged <5 years hospitalized with diarrhea, of which 16,458 (23.3%) were rand",
  "category": "epidemiology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Heidi  M. Soeters",
  "journal_published_doi": null,
  "corresponding_institution": "Independent Researcher"
}

{
  "doi": "10.64898/2026.07.25.26358905",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.25.26358905v1",
  "title": "Prevalence, determinants, and cardiometabolic consequences of overweight and obesity among people with Down syndrome: a systematic review and meta-analysis.",
  "source": "medrxiv",
  "authors": "Nambooze, R.; Pitua, I.; Bongomin, F.; Walakira, E. J.; Hove, G. V.; Schauwer, E. D.",
  "version": "1",
  "abstract": "ObjectiveThis systematic review and meta-analysis synthesised the global prevalence of overweight and obesity in people with Down syndrome (DS) across the lifespan, characterised determinants of excess adiposity, and examined associations with adverse cardiometabolic outcomes. MethodsSix databases were searched without date or language restriction. Two independent reviewers screened studies, extracted data, and assessed quality using the Joanna Briggs Institute Critical Appraisal Checklist for Prevalence Studies. Prevalence was pooled using a random- effects logit model. A pre-specified subgroup analysis by age band was conducted. Publication bias was assessed with Eggers test and certainty of evidence with Grading of Recommendations Assessment, Development and Evaluation (GRADE). ResultsTwenty-six studies (7,840 individuals; 14 countries) were included. The pooled prevalence was 18% (95% CI 15-22%) in children and adolescents, 36% (95% CI 26-47%) in adults, and 30% (95% CI 20-43%) in mixed-age cohorts; the test for subgroup differences was significant ({chi}{superscript 2}{square}= 14.39, p = 0.0007). The overall pooled prevalence was 22% (95% CI 18-26%; prediction interval 7-53%;",
  "category": "endocrinology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Rosemary Nambooze",
  "journal_published_doi": null,
  "corresponding_institution": "Angel's Center for Children with Special Needs, P.O. Box 98, Nansana, Wakiso District, Uganda"
}

{
  "doi": "10.64898/2026.07.27.26359028",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.27.26359028v1",
  "title": "Participant Experience with the SpaceLabs 90227 ABPM and SOMNOmedics ABPM Pro Devices",
  "source": "medrxiv",
  "authors": "Soddano, J.; Fernandez-Sedano, B.; Shurovi, S.; David, M. L.; Ding, G.; Dansoko, F.; Schwartz, J. E.; Abdalla, M.",
  "version": "1",
  "abstract": "Ambulatory blood pressure monitoring (ABPM) is recommended for confirming hypertension and assessing out-of-office blood pressure (BP). However, patient burden and device tolerability may limit broader implementation. We compared participant experience with a traditional oscillometric ABPM device and a compact cuff-integrated ABPM. The PRO-BP Study was a pilot randomized crossover study of 20 adults in New York City. Participants completed two 24-hour ABPM periods over 7 days using the SpaceLabs 90227 and SOMNOmedics ABPM Pro devices. After each period, participants rated comfort, pain, sleep interference, embarrassment, noise, skin irritation, and interference with daytime activities. Both devices achieved guideline-based recording-quality thresholds. Compared with SpaceLabs, ABPM Pro was associated with greater comfort (median 7.0 [IQR, 5.0-8.5] vs 3.5 [IQR, 2.0-6.5]; P=0.004), less pain (1.5 [0-3.5] vs 5.0 [0.5-7.0]; P=0.003), and less embarrassment (0.5 [0-3.5] vs 3.0 [0-6.0]; P=0.01). Other experience ratings did not differ significantly. Participant experience should be considered alongside recording quality when evaluating validated ambulatory BP monitoring technologies.",
  "category": "cardiovascular medicine",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Marwah Abdalla",
  "journal_published_doi": null,
  "corresponding_institution": "Columbia University Irving Medical Center"
}

{
  "doi": "10.64898/2026.02.16.26346377",
  "url": "https://www.medrxiv.org/content/10.64898/2026.02.16.26346377v3",
  "title": "Ensuring anatomical specificity in lesion network mapping: a multicentre study of 2,950 stroke patients",
  "source": "medrxiv",
  "authors": "Petersen, M.; Patil, K. R.; Eickhoff, S. B.; Biessels, G. J.; Meta VCI Map Consortium,  ",
  "version": "3",
  "abstract": "As many neurobehavioural functions rely on distributed brain networks, anatomically diverse brain lesions can cause highly similar neurobehavioural deficits. Lesion network mapping (LNM) builds on this principle to identify symptom-specific brain networks by mapping focal lesions onto a normative functional connectome. Recent work, however, questioned the anatomical specificity of LNM, showing that commonly used LNM procedures converge on nonspecific properties of the normative connectome rather than symptom-specific networks. Here, we investigated whether anatomically specific LNM can be achieved through appropriate study design and statistical inference. Using a multicenter dataset of 2,950 stroke patients across 12 cohorts, we compared lesion-derived connectivity maps between patients with and without impairment across six cognitive domains. We evaluated group differences using both permutation of symptom labels and parametric two-sample inference, and additionally examined a one-sample approach similar to what was used in the previous critique. Both two-sample approaches yielded distinct, biologically plausible lesion network maps with evident domain-specific features, and limi",
  "category": "neurology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Marvin Petersen",
  "journal_published_doi": null,
  "corresponding_institution": "University Medical Center Utrecht"
}

{
  "doi": "10.1101/2024.09.23.24314227",
  "url": "https://www.medrxiv.org/content/10.1101/2024.09.23.24314227v2",
  "title": "Personal protective beliefs and behaviors during the COVID-19 pandemic at a large, multi-campus, public university in Pennsylvania: a cross-sectional survey",
  "source": "medrxiv",
  "authors": "Stachowski Bell, J.; Chen, W.; Kim, R. E.; Murphy, R. P.; Pomerantz, L. D.; Kuruppumullage Don, P.; Long, B. A.",
  "version": "2",
  "abstract": "Introduction: The COVID-19 pandemic impacted many higher education institutions. Understanding the personal protective beliefs and behaviors surrounding public health measures such as face masking, social distancing, and handwashing helps to inform public health outreach measures. Objective: This study evaluates the beliefs and occurrences of face masking, social distancing, and handwashing behaviors among people at a multi-campus, public university in Pennsylvania. Methods: From October 5-November 30, 2021, a 10-minute REDCap survey was available to students, faculty, and staff 18 years of age and older at the Pennsylvania State University (PSU). Recruitment included targeted email, social media, digital advertisements, and university newspapers. 4,231 responses were received. Simple percentage associations between the selected factors and face masking behaviors as well as beliefs on the origin of the COVID-19 virus were made with IBM SPSS Statistics, version 29.0.2.0 (20). Results: Of 3,662 completed surveys, 65.2% of respondents were positive that facemasks prevented the transmission of airborne disease, 49.9% of the respondents stated that they wore facemasks always (27.9%), al",
  "category": "public and global health",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Bradley A Long",
  "journal_published_doi": null,
  "corresponding_institution": "Pennsylvania State University"
}

{
  "doi": "10.64898/2026.07.24.26358842",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.24.26358842v3",
  "title": "SSRI treatment of obsessive-compulsive disorder as motion across a bistable fold: A calibrated circuit-plasticity model of response, remission, and augmentation",
  "source": "medrxiv",
  "authors": "Sundaresan, S.",
  "version": "3",
  "abstract": "SSRIs are first-line for obsessive-compulsive disorder (OCD), yet benefit is partial, weeks-delayed, and severity-gated, and augmentation is empirical. The stable-states view is established but not drug-specific. We supply the missing coupling: a calibrated object joining serotonin pharmacokinetics, a basal-ganglia-thalamocortical circuit, and corticostriatal plasticity, in which OCD is an elevated fixed point and SSRI treatment moves this bistable state across a saddle-node fold (a tipping point). With [~]35 constants fixed, two shared parameters reproduce six SSRIs (RMS 0.83 Y-BOCS points, 84 arm-timepoints) and predict a held-out trial (0.58). A fold-free model fits the means equally well, so the mean cannot separate them; they diverge only on individual-level signatures it cannot produce -- a discrete, durable off-drug remission subgroup and critical slowing -- with qualitative support in OCD and adjacent disorders, not yet tested as bistability signatures. These, not the mean, decide who remits and relapses; the same geometry reframes memantine and antipsychotic augmentation.",
  "category": "psychiatry and clinical psychology",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Sankaran Sundaresan",
  "journal_published_doi": null,
  "corresponding_institution": "Princeton University"
}

{
  "doi": "10.1101/2025.10.14.25338013",
  "url": "https://www.medrxiv.org/content/10.1101/2025.10.14.25338013v2",
  "title": "Monocyte-to-Lymphocyte Ratio and Cardiovascular Outcomes in Individuals with Chronic Kidney Disease: A Systematic Review of Observational Studies",
  "source": "medrxiv",
  "authors": "Messanga Bessala, R. D.; Vugugaha, V. B.; Nketia, R.; Vivian Njoya, C. K.; Ngo Kam, E. H.",
  "version": "2",
  "abstract": "Aim: To evaluate the association between monocyte-to-lymphocyte ratio (MLR) and cardiovascular outcomes in chronic kidney disease (CKD). Methods: We systematically searched Medline, EMBASE, Web of Science, and Scopus from inception to May 28, 2025. We included peer-reviewed observational studies assessing MLR and cardiovascular outcomes or all-cause death in CKD. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Newcastle-Ottawa Scale. Findings were narratively synthesized and p-values pooled using Fisher's method. Statistical significance was set at p<0.05. Results: Eleven studies (n = 18,631) met our inclusion criteria. The study population ranged from non-dialysis CKD to end-stage kidney disease on dialysis, with follow-up from 1 to 24 months. Five studies (n = 16,974) examined cardiovascular death and generally reported significant associations with elevated MLR; Fisher's method indicated strong overall evidence (p<0.001). Six studies (n = 4,587) assessed cardiovascular events, yielding inconsistent findings, although some reported significant associations and identified predictive thresholds (for instance, 0.43). Five studies (n ",
  "category": "cardiovascular medicine",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Rostand Dimitri Messanga Bessala",
  "journal_published_doi": null,
  "corresponding_institution": "Newcastle University, United Kingdom"
}

{
  "doi": "10.64898/2026.07.17.26358332",
  "url": "https://www.medrxiv.org/content/10.64898/2026.07.17.26358332v2",
  "title": "Design tensions in a two-sided marketplace for reusable digital therapeutics software components: a qualitative interview study",
  "source": "medrxiv",
  "authors": "Melamed, S.; Merz, Y.; Nissen, M.; Kowatsch, T.",
  "version": "2",
  "abstract": "ObjectivesTo identify stakeholder-perceived design tensions in a two-sided marketplace for reusable digital therapeutics (DTx) software components and to use these tensions to propose alternative marketplace concepts. MethodsWe conducted 24 semi-structured interviews with digital health researchers and professionals. Data were analysed using hybrid deductive-inductive codebook thematic analysis. The Magic Triangle provided the initial deductive structure. One researcher coded all transcripts; a second independently applied the developing codebook to five transcripts to refine definitions and consistency. Seventeen parent themes were synthesized into 12 design tensions, which informed three authorgenerated marketplace concepts. ResultsParticipants described trade-offs concerning target users and host, component scope and customization, quality labels, verification, geographic scope, pricing, interoperability, platform launch, risks and market niche. The resulting concepts emphasized a regional startup ecosystem, a research-oriented hybrid marketplace or a global marketplace with stricter entry requirements. DiscussionThe concepts combine the tensions in different ways and highlight ",
  "category": "health informatics",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Tobias Kowatsch",
  "journal_published_doi": null,
  "corresponding_institution": "University of Zurich"
}

{
  "doi": "10.1101/2024.09.26.24313895",
  "url": "https://www.medrxiv.org/content/10.1101/2024.09.26.24313895v2",
  "title": "Loss-of-function of RNA-binding protein PRRC2B causes translational defects and cardiovascular malformation",
  "source": "medrxiv",
  "authors": "Das, D.; Ivanov, A.; Khor, E.-S.; Jiang, F.; Yang, L.; Zhou, S.; He, J.; Kawakami, Y.; Wainwright, L.; Geiger, J.; Meng, F.; Liu, H.; Jin, Z.; Porter, G.; Murphy, P. J.; Yao, P.",
  "version": "2",
  "abstract": "Alternative splicing of pre-mRNA generates variant protein forms from a given gene, accounting for both functional redundancy and diversification. A novel RNA-binding protein, Pro-rich Coiled-coil Containing Protein 2B (PRRC2B), has been shown to mediate both upstream (u)ORF-dependent and independent regulation of translation initiation, which is essential for cell cycle progression and proliferation. We identified two alternative spliced isoforms of PRRC2B mRNA in human and mouse hearts, as well as in multiple cell types: the full-length and the exon 16-excluded isoform {triangleup}E16. A congenital heart disease-associated human mutation-mimicking knock-in of the equivalent variant in the mouse genome results in the depletion of full-length Prrc2b mRNA, but not the alternative spliced truncated form {triangleup}E16. This mouse model does not cause any apparent structural or functional cardiac disorders. In contrast, global genetic inactivation of the Prrc2b gene in the mouse genome, nullifying both mRNA isoforms, caused patent ductus arteriosus (PDA) and neonatal lethality. Bulk and single-nucleus transcriptome profiling analyses of embryonic mouse hearts at E18.5 demonstrate a s",
  "category": "cardiovascular medicine",
  "published_at": "2026-07-28T00:00:00.000Z",
  "corresponding_author": "Peng Yao",
  "journal_published_doi": null,
  "corresponding_institution": "Aab Cardiovascular Research Institute, Department of Medicine, Department of Biochemistry & Biophysics, The Center for RNA Biology, University of Rochester Scho"
}